Consolidated Statement Of Cash Flows

SANTEN PHARMACEUTICAL CO.,LTD. - Filing #7254751

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
JPY
36,256,000,000 JPY
36,256,000,000 JPY
-403,000,000 JPY
35,853,000,000 JPY
26,642,000,000 JPY
26,642,000,000 JPY
26,703,000,000 JPY
JPY
60,000,000 JPY
Depreciation and amortization
17,948,000,000 JPY
18,178,000,000 JPY
Impairment losses (reversal of impairment losses)
1,302,000,000 JPY
7,779,000,000 JPY
Share of loss (profit) of investments accounted for using equity method
685,000,000 JPY
7,575,000,000 JPY
Income tax expense
11,628,000,000 JPY
3,171,000,000 JPY
Decrease (increase) in inventories
-8,381,000,000 JPY
-1,369,000,000 JPY
Other
2,822,000,000 JPY
1,533,000,000 JPY
Subtotal
72,747,000,000 JPY
84,633,000,000 JPY
Interest received
1,048,000,000 JPY
467,000,000 JPY
Dividends received
413,000,000 JPY
486,000,000 JPY
Interest paid
-1,093,000,000 JPY
-830,000,000 JPY
Net cash provided by (used in) operating activities
60,928,000,000 JPY
72,649,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-6,662,000,000 JPY
-9,319,000,000 JPY
Purchase of intangible assets
-4,357,000,000 JPY
-1,368,000,000 JPY
Other
-356,000,000 JPY
126,000,000 JPY
Net cash provided by (used in) investing activities
-8,223,000,000 JPY
-6,145,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-158,000,000 JPY
-2,112,000,000 JPY
Purchase of treasury shares
-37,883,000,000 JPY
-16,962,000,000 JPY
Dividends paid
-12,111,000,000 JPY
-11,881,000,000 JPY
Other
0 JPY
217,000,000 JPY
Net cash provided by (used in) financing activities
-53,307,000,000 JPY
-34,031,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-602,000,000 JPY
32,473,000,000 JPY
Cash and cash equivalents
92,997,000,000 JPY
94,582,000,000 JPY
57,903,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-983,000,000 JPY
4,206,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.